Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
Go back to Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer(NASDAQ: MNPR) | Delayed: 0.64 -0.04 (5.88%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.68 | 52 Week High | $ | |||
Open | $0.68 | 52 Week Low | $ | |||
Day High | $0.68 | P/E | N/A | |||
Day Low | $0.62 | EPS | $ | |||
Volume | 24,182 |